Comparison of the effects of immunosuppressive factors from newly established colon carcinoma cell cultures on human lymphocyte proliferation and cytokine secretion

Tumor Biology

Volumn 21, Issue 1, 2000, Pages 11-20

  Luo, Jiansong ^b   Kammerer, Robert ^b   Von Kleist, Sabine ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

Colorectal carcinoma; Cytokine secretion; Immunosuppressive factor; Lymphocyte proliferation; Prostaglandin E2; Tumor cell supernatant

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE SUBPOPULATION; TUMOR ESCAPE;

EID: 0033971307     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030106     Document Type: Article

References (20)

1. Bateman WJ, Donnellan I, Fraser IA, Wong LS, Morris AG: Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma. Cancer Immunol Immunother 1995;41:61-67.
2. Musatti CC, Yasaka K, Santos LM: Impaired proliferative response and low interleukin-2 production in patients with lymphoma. Braz J Med Biol Res 1987;20:351-362.
3. Elsässer-Beile U, von Kleist S, Fischer R, Mönting JS: Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls. J Clin Lab Anal 1992;6:311-314.
4. Elsässer-Beile U, von Kleist S, Sauther W, Gallati H, Schulte Mönting JS: Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages. Br J Cancer 1993;68:32-36.
5. Sulitzeanu D: Immunosuppressive factors in human cancer. Adv Cancer Res 1993;60:247-267.
6. Ebert EC, Roberts AI, O'Connell SM, Robertson FM, Nagase H: Characterization of an immunosuppressive factor derived from colon cancer cells. J Immunol 1987;138: 2161-2168.
7. Allen PD, Johnston DH, Macey MG, Williams NS, Newland AC: Colorectal cell line suppression of lymphokine activated killer cell generation is reversed by suramin. Anticancer Drugs 1995;6:250-258.
8. Rolland PH, Martin PM, Jacquemier J, Rolland AM, Toga M: Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 1980;64:1061-1070.
9. Young MR, Hoover CS: Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma. J Natl Cancer Inst 1986;77:425-429.
10. Stanojevic-Baki N, Vockovic-Dekic L, Susnjar S, Spuzic I: In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients. Neoplasma 1992;39:129-132.
11. Kammerer R, von Kleist S: CEA expression on the surface of colorectal carcinomas correlates with their resistance against LAK-cell lysis. Int J Cancer 1994;57:341-347.
12. Matsuda M, Petersson M, Lenke IR, Taupin JL, Magnusson I, Mellstedt H, Anderson P, Kiessling R: Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease. Int J Cancer 1995;61:765-772.
13. Ding L, Isobe K, Yoshida T, Nakashima I: Suppression of lymphocyte signal transduction by murine mastocytoma ascites. Microbiol Immunol 1991;35:767-774.
14. Fariñas MC, Rodriguez-Valverde V, Zarrabeitia MT, Parra-Blanco JA, Sanz-Ortiz J: Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer. Cancer 1991;68:1279-1284.
15. Johnson RB Jr: Monocytes and macrophages. N Engl J Med 1988; 318:747-752.
16. 2. J Immunol 1994;153: 1674-1685.
17. Hirabayashi H, Yasumura S, Lin WC, Amoscato A, Johnson JT, Herberman RB, Whiteside TL: Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells. Arch Otolaryngol Head Neck Surg 1995;12:285-292.
18. Trentin L, Zambello R, Bulian P, Cerutti A, Enthammer C, Cassatella M, Nitti D, Lise M, Agostini C, Semenzato G: Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor. Br J Cancer 1995;71:240-245.
19. Young MI, Wright MA, Lozano Y, Matthews JP: Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer. Int J Cancer 1996;67:333-338.
20. Chao TY, Ting CS, Yeh MY, Chang JY, Wang CC, Chu TM: Effects of indomethacin on lymphokine-activated killer cell activities in cancer patients. Tumor Biol 1995;16:230-242.